Maltodextrin
- Generic Name
- Maltodextrin
- Drug Type
- Small Molecule
- CAS Number
- 9050-36-6
- Unique Ingredient Identifier
- 7CVR7L4A2D
A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy
- First Posted Date
- 2014-08-13
- Last Posted Date
- 2014-08-13
- Lead Sponsor
- Prim. Prof. Dr. Oliver Findl, MBA
- Target Recruit Count
- 60
- Registration Number
- NCT02215330
- Locations
- 🇦🇹
Oliver Findl, Vienna, Austria
Study of Sc-FOS for Pouchitis Prevention
Phase 1
Completed
- Conditions
- Pouchitis
- Interventions
- Drug: Short-Chain Fructooligosaccharide
- First Posted Date
- 2014-07-30
- Last Posted Date
- 2020-02-24
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 13
- Registration Number
- NCT02203955
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
GOS Prebiotic Effect in Children Constipation
Phase 1
Completed
- Conditions
- Constipation
- Interventions
- Dietary Supplement: Galactooligosaccharide prebiotic
- First Posted Date
- 2014-07-08
- Last Posted Date
- 2014-07-08
- Lead Sponsor
- University of Campinas, Brazil
- Target Recruit Count
- 20
- Registration Number
- NCT02183766
Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim2)
Phase 2
Completed
- Conditions
- Insulin Sensitivity
- Interventions
- First Posted Date
- 2014-04-30
- Last Posted Date
- 2020-09-11
- Target Recruit Count
- 69
- Registration Number
- NCT02127125
- Locations
- 🇺🇸
Audie L. Murphy VA Hospital, STVHCS, San Antonio, Texas, United States
Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim 1)
Phase 2
Completed
- Conditions
- Insulin Sensitivity
- Interventions
- First Posted Date
- 2014-04-28
- Last Posted Date
- 2021-10-15
- Target Recruit Count
- 20
- Registration Number
- NCT02124759
- Locations
- 🇺🇸
Audie L. Murphy VA Hospital, STVHCS, San Antonio, Texas, United States
Effect of Protein Supplementation After Bariatric Surgery
Not Applicable
Completed
- Conditions
- Protein Malnutrition
- Interventions
- Drug: Resource Instant Protein 88
- First Posted Date
- 2013-12-05
- Last Posted Date
- 2013-12-05
- Lead Sponsor
- University of Hohenheim
- Target Recruit Count
- 35
- Registration Number
- NCT02001636
- Locations
- 🇩🇪
Department of General, Visceral and Transplant Surgery, University Hospital of Tübingen, Tuebingen, Germany
Methylphenidate as Treatment Option of Fatigue in Multiple Sclerosis
Phase 2
- Conditions
- FatigueMultiple Sclerosis
- Interventions
- First Posted Date
- 2013-06-17
- Last Posted Date
- 2015-05-12
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 96
- Registration Number
- NCT01879202
- Locations
- 🇦🇹
Medical University of Vienna, Department of Neurology, Vienna, Austria
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath